Satoshi Iyama

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

Michel Attal, Paul G. Richardson, S. Vincent Rajkumar et al. · The Lancet · 2019 · 620 citations

Hematological Malignancy, Medicine, Immunology +6

Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion

Yasushi Sato, Hironobu Araki, Junji Kato et al. · Blood · 2005 · 613 citations

Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells

Naotaka Hayasaka, Kohichi Takada, Hajime Nakamura et al. · Scientific Reports · 2019 · 155 citations · Full text

Ex Vivo Large‐Scale Generation of Human Platelets from Cord Blood CD34 ⁺ Cells

Takuya Matsunaga, Ikuta Tanaka, Masayoshi Kobune et al. · Stem Cells · 2006 · 128 citations · Full text

Drug resistance is dramatically restored by hedgehog inhibitors in CD34⁺ leukemic cells

Masayoshi Kobune, Rishu Takimoto, Kazuyuki Murase et al. · Cancer Science · 2009 · 124 citations · Full text

Hematological Malignancy, Active Hh Signaling, Lineage Plasticity +14